EP3393512
Stökkbrigði af RSV F prótíni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.12.2016EP published:
19.11.2025EP application number:
16816405.1
EP translation filed:
29.12.2025Grant published:
14.1.2026EPO information:
European Patent Register
Max expiry date:
8.12.2036Expiry date:
8.12.2026Next due date:
31.12.2026
Title in English:
RSV F PROTEIN MUTANTSLanguage of the patent:
English
Timeline
Today
9.12.2016EP application
19.11.2025EP Publication
29.12.2025Translation submitted
14.1.2026Registration published
8.12.2026Expires
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
CHE, YeAddress:
Groton CT 06340, US
Name:
DORMITZER, Philip RalphAddress:
Armonk NY 10504, US
Name:
GRIBENKO, Alexey VyacheslavovichAddress:
New City NY 10956, US
Name:
HANDKE, Luke DavidAddress:
Nyack NY 10960, US
Name:
PRASAD, Avvari KrishnaAddress:
Chapel Hill NC 27516, US
Name:
QIU, XiayangAddress:
Mystic CT 06355, US
Name:
RUPPEN, Mark EdwardAddress:
Garnerville NY 10932, US
Name:
SONG, XiAddress:
Waterford CT 06385, US
Name:
SWANSON, Kena AnneAddress:
Pearl River NY 10965, US
Name:
KODALI, SrinivasAddress:
Hillsborough NJ 08844, US
Name:
XU, XinAddress:
Mahwah NJ 07430, US
Name:
EFFEREN, KariAnn SweeneyAddress:
Stamford CT 06905, US
Name:
CAI, PingAddress:
New City NY 10956, US
Name:
TOMPKINS, Kristin RachaelAddress:
Garrison NY 10524, US
Name:
NUNEZ, Lorna Del PilarAddress:
Briarcliff Manor NY 10510, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562387270 PDate:
23.12.2015Country:
US
Number:
201662421184 PDate:
11.11.2016Country:
US
Classification
Categories:
A61K 39/155, A61K 39/12, C07K 14/005
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 22.12.2025
Expires: 8.12.2026
Payer: Árnason Faktor ehf.